Dose proportionality assessment determines whether plasma concentrations increase linearly with dose increments or exhibit non-linear kinetics from saturation phenomena. Linear kinetics produce proportional dose-concentration relationships supporting simple dose adjustments. Non-linear kinetics from enzyme saturation or absorption saturation necessitate careful dose titration. Michaelis-Menten kinetics characterise saturable metabolism guiding dose optimisation.
Population pharmacokinetic analysis incorporates dose-concentration relationships identifying saturation thresholds. Regulatory submissions incorporate dose proportionality data supporting dose selection. Clinical monitoring detects unexpected exposure accumulation indicating non-linear kinetics. Biomarker-driven dosing accounts for non-proportional kinetics optimising therapy. Emerging population pharmacokinetics enables individualised dose predictions.
General Biopharmaceutical Concepts
Dose Proportionality Assessment
Dose proportionality assessment evaluates whether systemic drug exposure increases proportionally with increasing dose over a defined dose range.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →